Goiter epidemiology and demographics: Difference between revisions
No edit summary |
|||
Line 4: | Line 4: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
The incidence of Goiter is approximately 1400 - 1700 in females and 900 in males per 100,000 individuals worldwide. *The prevalence of Goiter is approximately 3000 for single thyroid nodules per 100,000 individuals worldwide. The frequency of Goiter increases in women over 45 years of age. The rate of occurrence of Goiter in both males and females occurs at a female-to-male ratio of 4:1. There is no racial predilection to Goiter. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 15:34, 18 September 2017
Goiter Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Goiter epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Goiter epidemiology and demographics |
Risk calculators and risk factors for Goiter epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The incidence of Goiter is approximately 1400 - 1700 in females and 900 in males per 100,000 individuals worldwide. *The prevalence of Goiter is approximately 3000 for single thyroid nodules per 100,000 individuals worldwide. The frequency of Goiter increases in women over 45 years of age. The rate of occurrence of Goiter in both males and females occurs at a female-to-male ratio of 4:1. There is no racial predilection to Goiter.
Epidemiology and Demographics
Incidence
- The incidence of Goiter is approximately 1400 - 1700 in females and 900 in males per 100,000 individuals worldwide. [1] [2] [3]
Prevalence
- The prevalence of Goiter is approximately 3000 for single thyroid nodules per 100,000 individuals worldwide. [4] [5] [6]
Age
Sex
- The rate of occurrence of Goiter in both males and females occurs at a female-to-male ratio of 4:1. [8]
Race
- There is no racial predilection to Goiter.
References
- ↑ VANDER JB, GASTON EA, DAWBER TR (1954). "Significance of solitary nontoxic thyroid nodules; preliminary report". N Engl J Med. 251 (24): 970–3. doi:10.1056/NEJM195412092512403. PMID 13214371.
- ↑ Freire-Maia, Ademar; Freire-Maia, Dértia Villalba; Morton, Newton E. (1982). "Epidemiology and Genetics of Endemic Goiter". Human Heredity. 32 (3): 176–180. doi:10.1159/000153286. ISSN 1423-0062.
- ↑ Freire-Maia DV, Freire-Maia A, Schull WJ, Morton NE, Quelce-Salgado A, Lobo LC (1983). "Epidemiology and genetics of endemic goiter. I. Epidemiological aspects". Isr. J. Med. Sci. 19 (1): 11–6. PMID 6832943.
- ↑ 4.0 4.1 Vanderpump MP (2011). "The epidemiology of thyroid disease". Br. Med. Bull. 99: 39–51. doi:10.1093/bmb/ldr030. PMID 21893493.
- ↑ Vanderpump, M. P. J. (2011). "The epidemiology of thyroid disease". British Medical Bulletin. 99 (1): 39–51. doi:10.1093/bmb/ldr030. ISSN 0007-1420.
- ↑ Zimmermann MB (2009). "Iodine deficiency". Endocr Rev. 30 (4): 376–408. doi:10.1210/er.2009-0011. PMID 19460960.
- ↑ Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F (1995). "The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey". Clin. Endocrinol. (Oxf). 43 (1): 55–68. PMID 7641412.
- ↑ Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977). "The spectrum of thyroid disease in a community: the Whickham survey". Clin. Endocrinol. (Oxf). 7 (6): 481–93. PMID 598014.